Which of the following genetically engineered organisms was used by Eli Lilly to prepare human insulin?

The correct option is Bacterium.

Step-by-step explanation:

1. In 1983, the American pharmaceutical company Eli Lilly successfully prepared and marketed human insulin (known as Humulin) using recombinant DNA technology.
2. Human insulin consists of two short polypeptide chains: chain A and chain B, which are linked together by disulfide bridges.
3. The company synthesized two DNA sequences corresponding to the A and B chains of human insulin.
4. These DNA sequences were introduced into plasmids of the bacterium Escherichia coli (E. coli) to produce insulin chains.
5. The A and B chains were produced separately in the bacterial hosts, extracted, and then combined by creating disulfide bonds to form mature human insulin.
6. Therefore, the genetically engineered organism used for this process was a bacterium (specifically, E. coli).